Skip to main content

Together we are beating cancer

Donate now

Research and trials

Showing 12 out of 1701 results
This entry is part 1 of 5 in the series Google Hangouts
%postcontent%

Our scientists have discovered that similar to a rugby maul, cancer cells can ward off tumour-killing immune cells through an important cellular signal. Our scientists have discovered that similar to a rugby maul, cancer cells can ward off tumour-killing immune cells through an important cellular signal.

by Alan Worsley | Analysis | 25 September 2015

25 September 2015

Alan
  • Science & Technology
  • Health & Medicine

Our milestones: the birth of abiraterone for prostate cancer

We look back to the 1990s, and to our 'first-in-man' trial of prostate cancer drug abiraterone - a vital step in the drug's development We look back to the 1990s, and to our 'first-in-man' trial of prostate cancer drug abiraterone - a vital step in the drug's development

by Henry Scowcroft | Analysis | 21 September 2015

21 September 2015

This entry is part 24 of 30 in the series Our milestones
%postcontent%
F1-Pitstop

We spoke to two of our own experts about how they're targeting fundamental repair processes in our cells to tip cancer cells over the edge. We spoke to two of our own experts about how they're targeting fundamental repair processes in our cells to tip cancer cells over the edge.

by Emma Smith | Analysis | 18 September 2015

18 September 2015

We quiz our chief clinician, Professor Peter Johnson, to get his take on the history of cancer immunotherapy and where the field is heading. We quiz our chief clinician, Professor Peter Johnson, to get his take on the history of cancer immunotherapy and where the field is heading.

by Henry Scowcroft | Analysis | 17 September 2015

17 September 2015